1. Home
  2. SXT vs LNTH Comparison

SXT vs LNTH Comparison

Compare SXT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXT
  • LNTH
  • Stock Information
  • Founded
  • SXT 1882
  • LNTH 1956
  • Country
  • SXT United States
  • LNTH United States
  • Employees
  • SXT N/A
  • LNTH N/A
  • Industry
  • SXT Major Chemicals
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SXT Industrials
  • LNTH Health Care
  • Exchange
  • SXT Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • SXT 4.0B
  • LNTH 3.6B
  • IPO Year
  • SXT N/A
  • LNTH 2015
  • Fundamental
  • Price
  • SXT $95.32
  • LNTH $55.07
  • Analyst Decision
  • SXT Buy
  • LNTH Buy
  • Analyst Count
  • SXT 2
  • LNTH 6
  • Target Price
  • SXT $110.00
  • LNTH $74.50
  • AVG Volume (30 Days)
  • SXT 490.1K
  • LNTH 1.7M
  • Earning Date
  • SXT 10-31-2025
  • LNTH 11-05-2025
  • Dividend Yield
  • SXT 1.72%
  • LNTH N/A
  • EPS Growth
  • SXT 53.07
  • LNTH N/A
  • EPS
  • SXT 3.17
  • LNTH 3.77
  • Revenue
  • SXT $1,575,588,000.00
  • LNTH $1,520,653,000.00
  • Revenue This Year
  • SXT $4.42
  • LNTH N/A
  • Revenue Next Year
  • SXT $5.78
  • LNTH $2.91
  • P/E Ratio
  • SXT $30.11
  • LNTH $14.59
  • Revenue Growth
  • SXT 4.95
  • LNTH 5.75
  • 52 Week Low
  • SXT $66.15
  • LNTH $47.25
  • 52 Week High
  • SXT $121.54
  • LNTH $118.21
  • Technical
  • Relative Strength Index (RSI)
  • SXT 41.38
  • LNTH 54.40
  • Support Level
  • SXT $92.09
  • LNTH $52.21
  • Resistance Level
  • SXT $94.98
  • LNTH $53.97
  • Average True Range (ATR)
  • SXT 2.65
  • LNTH 1.68
  • MACD
  • SXT 0.48
  • LNTH 0.74
  • Stochastic Oscillator
  • SXT 60.69
  • LNTH 78.72

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are; Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: